Replies to post #329058 on Avid Bioservices Inc (CDMO)

[The Other Guy]

Jeff Hutchins

[biopharm]

The individuals involved in certain PS Targeting activity also have some other excuses in common

Personal reasons

Dr Jedd Wolchok backs out of talking about how PS Targeting combo helps stop off target toxicities etc due to personal reasons

Roger Lias CEO Peregrine / Avid leaves due to personal reasons

FDA Commissioner Scott Gottlieb resigns due to personal reasons (1 month later poached over to New Enterprise Associates)

There were lots more and I am sure David Mott has his finger in the mix

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134141703

Such a shame that many in Big Pharma never really wanted a cure to many such a disease it seems, and the few that resisted falling in line to Big Pharma just so happen to suddenly pass away. There seems to be an awakening going on though because it can't be hidden much longer

Professor Brian Foxwell, Professor of Immune Cell Signalling at Imperial College and a senior investigator at the Kennedy Institute of Rheumatology, unexpectedly passed away on 17 December, 2008. Brian Foxwell received his PhD from the University of Bristol in 1981, followed by a post doctorate at the Imperial Cancer Research Fund (now Cancer Research UK), where he worked with Andy Creighton and Phil Thorpe on the development of monoclonal antibodies as drug-targeting agents for cancer therapy.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688263/